Logo image of SEER

SEER INC (SEER) Stock Fundamental Analysis

NASDAQ:SEER - Nasdaq - US81578P1066 - Common Stock - Currency: USD

2.13  +0.01 (+0.47%)

Fundamental Rating

4

Overall SEER gets a fundamental rating of 4 out of 10. We evaluated SEER against 55 industry peers in the Life Sciences Tools & Services industry. While SEER has a great health rating, there are worries on its profitability. SEER is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

SEER had negative earnings in the past year.
In the past year SEER has reported a negative cash flow from operations.
SEER had negative earnings in each of the past 5 years.
SEER had a negative operating cash flow in each of the past 5 years.
SEER Yearly Net Income VS EBIT VS OCF VS FCFSEER Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 -20M -40M -60M -80M -100M

1.2 Ratios

With a Return On Assets value of -24.73%, SEER is not doing good in the industry: 70.91% of the companies in the same industry are doing better.
With a Return On Equity value of -27.61%, SEER perfoms like the industry average, outperforming 47.27% of the companies in the same industry.
Industry RankSector Rank
ROA -24.73%
ROE -27.61%
ROIC N/A
ROA(3y)-20.82%
ROA(5y)-16.61%
ROE(3y)-22.99%
ROE(5y)-18.14%
ROIC(3y)N/A
ROIC(5y)N/A
SEER Yearly ROA, ROE, ROICSEER Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 -5 -10 -15 -20 -25

1.3 Margins

SEER has a Gross Margin (50.66%) which is comparable to the rest of the industry.
In the last couple of years the Gross Margin of SEER has remained more or less at the same level.
SEER does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 50.66%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.13%
GM growth 5YN/A
SEER Yearly Profit, Operating, Gross MarginsSEER Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 -5K -10K

More info and screens

8

2. Health

2.1 Basic Checks

SEER does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for SEER has been reduced compared to 1 year ago.
The number of shares outstanding for SEER has been reduced compared to 5 years ago.
There is no outstanding debt for SEER. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
SEER Yearly Shares OutstandingSEER Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
SEER Yearly Total Debt VS Total AssetsSEER Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

2.2 Solvency

Based on the Altman-Z score of 0.37, we must say that SEER is in the distress zone and has some risk of bankruptcy.
SEER's Altman-Z score of 0.37 is on the low side compared to the rest of the industry. SEER is outperformed by 70.91% of its industry peers.
There is no outstanding debt for SEER. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 0.37
ROIC/WACCN/A
WACC8.87%
SEER Yearly LT Debt VS Equity VS FCFSEER Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M 400M 500M

2.3 Liquidity

SEER has a Current Ratio of 19.34. This indicates that SEER is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 19.34, SEER belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
A Quick Ratio of 18.81 indicates that SEER has no problem at all paying its short term obligations.
With an excellent Quick ratio value of 18.81, SEER belongs to the best of the industry, outperforming 98.18% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 19.34
Quick Ratio 18.81
SEER Yearly Current Assets VS Current LiabilitesSEER Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

More info and screens

5

3. Growth

3.1 Past

SEER shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -8.46%.
The Revenue has decreased by -2.33% in the past year.
The Revenue has been growing by 159.68% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-8.46%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%3.13%
Revenue 1Y (TTM)-2.33%
Revenue growth 3Y28.88%
Revenue growth 5Y159.68%
Sales Q2Q%37.15%

3.2 Future

The Earnings Per Share is expected to grow by 12.91% on average over the next years. This is quite good.
The Revenue is expected to grow by 38.90% on average over the next years. This is a very strong growth
EPS Next Y13.8%
EPS Next 2Y16.19%
EPS Next 3Y8.73%
EPS Next 5Y12.91%
Revenue Next Year25.01%
Revenue Next 2Y26.66%
Revenue Next 3Y36.11%
Revenue Next 5Y38.9%

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
SEER Yearly Revenue VS EstimatesSEER Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 20M 40M 60M
SEER Yearly EPS VS EstimatesSEER Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 -0.5 -1 -1.5

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for SEER. In the last year negative earnings were reported.
Also next year SEER is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
SEER Price Earnings VS Forward Price EarningsSEER Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
SEER Per share dataSEER EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y16.19%
EPS Next 3Y8.73%

More info and screens

0

5. Dividend

5.1 Amount

SEER does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

SEER INC

NASDAQ:SEER (8/1/2025, 8:02:17 PM)

2.13

+0.01 (+0.47%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)05-13 2025-05-13/amc
Earnings (Next)08-06 2025-08-06/amc
Inst Owners60.01%
Inst Owner Change0.42%
Ins Owners2.98%
Ins Owner Change-0.34%
Market Cap125.35M
Analysts80
Price Target3.06 (43.66%)
Short Float %3.31%
Short Ratio6.9
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)7.47%
Min EPS beat(2)-1.42%
Max EPS beat(2)16.35%
EPS beat(4)2
Avg EPS beat(4)2.23%
Min EPS beat(4)-10.69%
Max EPS beat(4)16.35%
EPS beat(8)5
Avg EPS beat(8)7.18%
EPS beat(12)9
Avg EPS beat(12)7.36%
EPS beat(16)12
Avg EPS beat(16)6.21%
Revenue beat(2)1
Avg Revenue beat(2)13.06%
Min Revenue beat(2)-0.72%
Max Revenue beat(2)26.85%
Revenue beat(4)2
Avg Revenue beat(4)11.43%
Min Revenue beat(4)-5.88%
Max Revenue beat(4)26.85%
Revenue beat(8)3
Avg Revenue beat(8)0.59%
Revenue beat(12)7
Avg Revenue beat(12)3.53%
Revenue beat(16)11
Avg Revenue beat(16)15.82%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0.89%
EPS NQ rev (3m)0.89%
EPS NY rev (1m)15.79%
EPS NY rev (3m)16.47%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-7.41%
Revenue NY rev (1m)0.69%
Revenue NY rev (3m)2.84%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 8.19
P/FCF N/A
P/OCF N/A
P/B 0.4
P/tB 0.4
EV/EBITDA N/A
EPS(TTM)-1.41
EYN/A
EPS(NY)-0.92
Fwd EYN/A
FCF(TTM)-0.86
FCFYN/A
OCF(TTM)-0.8
OCFYN/A
SpS0.26
BVpS5.28
TBVpS5.28
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -24.73%
ROE -27.61%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 50.66%
FCFM N/A
ROA(3y)-20.82%
ROA(5y)-16.61%
ROE(3y)-22.99%
ROE(5y)-18.14%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.13%
GM growth 5YN/A
F-Score5
Asset Turnover0.04
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 55.48%
Cap/Sales 22.76%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 19.34
Quick Ratio 18.81
Altman-Z 0.37
F-Score5
WACC8.87%
ROIC/WACCN/A
Cap/Depr(3y)149.91%
Cap/Depr(5y)200.28%
Cap/Sales(3y)45.15%
Cap/Sales(5y)185.27%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-8.46%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%3.13%
EPS Next Y13.8%
EPS Next 2Y16.19%
EPS Next 3Y8.73%
EPS Next 5Y12.91%
Revenue 1Y (TTM)-2.33%
Revenue growth 3Y28.88%
Revenue growth 5Y159.68%
Sales Q2Q%37.15%
Revenue Next Year25.01%
Revenue Next 2Y26.66%
Revenue Next 3Y36.11%
Revenue Next 5Y38.9%
EBIT growth 1Y5.51%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year15.94%
EBIT Next 3Y9.41%
EBIT Next 5Y11.5%
FCF growth 1Y28.06%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y22.79%
OCF growth 3YN/A
OCF growth 5YN/A